Biotech · Private company
enGene, Inc.
Track this companyFree. Adds enGene, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- EG-70 (phase 1)Phase 2 · Superficial Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- EG-70 (phase 2) Master ProtocolPhase 2 · Superficial Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- Surfactant Bladder Pre-Rinse and EG-70 (Substudy)Phase 2 · Superficial Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-NaïvePHASE1_PHASE2 · RECRUITING · started Apr 22, 2021ClinicalTrials.gov NCT04752722 · fetched Nov 12, 2026